Your genes are not linear blueprints but complex mosaics that require constant editing.

Your genes are not linear blueprints but complex mosaics that require constant editing.
Image: Intellect (generated)

In short: Most eukaryotic genes are not simple, continuous instructions. Instead, they are fragmented mosaics of coding exons and non-coding introns. To function, cells must perform RNA splicing, a sophisticated editing process that removes introns and stitches exons together, exponentially expanding the diversity of proteins our bodies can produce.

In 1977, researchers discovered that genes are not always linear sequences of nucleotides. Unlike bacterial genes, where DNA maps directly to protein, eukaryotic genes contain introns—intervening sequences that must be excised from the pre-mRNA transcript. This discovery, which earned Richard Roberts and Phillip Sharp the 1993 Nobel Prize in Physiology or Medicine, revealed that the flow of genetic information is far more complex than initially assumed.

The primary engine for this editing is the spliceosome, a dynamic ribonucleoprotein complex consisting of five small nuclear RNAs and numerous associated proteins. This machinery recognizes specific motifs at the boundaries of exons and introns, executing a two-step transesterification reaction to remove the introns and ligate the exons. Recent cryo-electron microscopy has provided high-resolution snapshots of this process, showing the structural rearrangements that drive these precise molecular cuts.

Beyond simple removal, splicing allows for alternative splicing, where exons are selectively included or excluded to create different mRNA isoforms. This process is remarkably pervasive, occurring in more than 95% of human multi-intron genes. By generating multiple, functionally distinct protein isoforms from a single gene, alternative splicing significantly expands the genome's coding potential. This flexibility helps organisms adapt to changing environments and contributes to evolutionary innovation.

Splicing is tightly regulated and often occurs co-transcriptionally, meaning it happens while the pre-mRNA is still being synthesized. The machinery is organized within the nucleus in specialized, membraneless structures called nuclear speckles and paraspeckles. When this process goes awry—due to mutations in spliceosomal proteins or genetic variants that disrupt splice sites—it can lead to disease. Consequently, targeting RNA splicing with therapeutics like antisense oligonucleotides has become a promising strategy for treating neurodegenerative disorders and certain cancers.

Opens the Intellect+ feed with this card first. Swipe up for the next one.

Sources

To cite this card, link to https://intellectplus.co.uk/app/science-rna-splicing.

How we source, check and correct cards: Editorial standards.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

Finding something worth knowing…